Special Issue "Understanding Inflammation-induced Mental Diseases: New Opportunities for Treatment"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (30 November 2018).
Interests: inflammation; fatigue; depression; sickness behavior; neuroimmunology; brain mechanisms; human wellbeing; animal welfare; quality of life
Interests: blood-brain interface, cytokine, food intake, inflammation, sickness behavior
Special Issues and Collections in MDPI journals
The focus of this Special Issue is on research that aims to understand the neuroimmune mechanisms that influence psychiatric disorders. Coming from studying of seemingly different fields of research, i.e., immunology, endocrinology, neuroscience, and pharmacology, elements that were previously considered to be domains of one discipline are now discovered in the other.
This Special Issue may include manuscripts on the role of immune system in triggering inflammation in the body and brain that affects regulatory circuits involved in emotion, motivation, and cognition. We hope that this Special Issue will clarify our understanding of the neuroimmune mechanisms that underlie the changes in activity in neural circuits controlling physiology and behavior, with important implications for public health with respect to stress, fatigue, anxiety, depression etc. This Special Issue is of particular importance because understanding these neuroimmune mechanisms could lead to novel therapeutic targets for mental illnesses.
In this Special Issue, we would like to cover the most recent neuroimmune correlates involved in brain pathology. Very welcome are studies proving a link between inflammation and clinical features such as chemistry, brain signals, neuro- and psychopathology, emotional and cognitive dysfunction.
We welcome original research, reviews, case reports, clinical trials, hypothesis and theory, methods, and perspectives, from international researchers and clinicians in this field. The purpose of this Special Issue is intended to provide the field with current approaches in psychoneuroimmunology and neuroimmunopharmacology that is hoped to improve and create therapeutic options for inflammation-related brain disorders.
Prof. Dr. S. Mechiel Korte
Dr. Jan-Pieter Konsman
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Mental Disorders
- Brain Mechanisms